According to RVL Pharmaceuticals's latest financial reports the company's current revenue (TTM) is €33.31 M. In 2022 the company made a revenue of €46.35 M an increase over the revenue in the year 2021 that were of €35.55 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.